NEW YORK (GenomeWeb News) – Genetic Technologies today said that it has reached a settlement with Roche 454 Life Sciences over alleged infringement of Genetic Technologies' primary non-coding DNA patent.

The Australian firm said that it has reached a settlement, covenant, and license agreement with 454, which also covers its affiliates within Roche. The terms of the agreement are confidential.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: methylation patterns in multiple myeloma, recent Y chromosome bottleneck, and more.

By studying the spectra of microbes on Earth, a team of researchers hopes to be better equipped to detect any on other worlds.

SolveBio's Mark Kaganovich says at TechCrunch that genomics needs an app to push it into the mainstream.

A University of Michigan team is using a Facebook app to recruit and keep in touch with participants in its 'Genes for Good' project.